BioMarin Promotes Lon Cardon to Chief Scientific Strategy Officer

Xconomy San Francisco — 

Lon Cardon, who has served as chief scientific officer at BioMarin Pharmaceutical (NASDAQ: BMRN) the past two years, has been promoted to a newly created position: chief scientific strategy officer. San Rafael, CA-based BioMarin says in the new role Cardon will be responsible for building the company’s drug pipeline. Before joining BioMarin, Cardon worked at GlaxoSmithKline (NYSE: GSK) as senior vice president of alternative discovery and development, and head of target sciences. BioMarin is preparing to file for FDA review of its experimental gene therapy for hemophilia.